AstraZeneca Group plc (AZN) CEO Pascal Soriot on Q2 2018 Results - Earnings Call Transcript [Seeking Alpha]
AstraZeneca PLC - American Depositary Shares (AZN)
Last astrazeneca plc - american depositary shares earnings: 2/5 04:00 pm
Check Earnings Report
US:NYSE Investor Relations:
astrazeneca.com/investor-relations.html
Company Research
Source: Seeking Alpha
AstraZeneca Group plc (NYSE: AZN ) Q2 2018 Earnings Conference Call July 26, 2018 7:30 AM ET Executives Pascal Soriot - Chief Executive Officer Dave Fredrickson - Executive Vice President, Oncology Business Unit Mark Mallon - Executive Vice President, GPPS, GMA, CA Marc Dunoyer - Chief Financial Officer Sean Bohen - Executive Vice President, Global Medicines Development and CMO Analysts Andrew Baum - Citi James Gordon - JP Morgan Simon Baker - Exane Emmanuel Papadakis - Barclays Jo Walton - Credit Suisse Sachin Jain - Bank of America Pascal Soriot Welcome to our First half-year of results presentation, conference call and webcast. We are here in London and we are live with a number of people present in the room, but we also have more people joining us by phone and by webcast. As always the presentation is available on astrazeneca.com and our website for you to download and we know that there are competing events today, so it’s probably reflected
Show less
Read more
Impact Snapshot
Event Time:
AZN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AZN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AZN alerts
High impacting AstraZeneca PLC - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
AZN
News
- ICH Q9 (R1) Quality Risk Management (QRM) Training Course (ONLINE EVENT) [Yahoo! Finance]Yahoo! Finance
- Bluecrux & Pharmaceutical Innovator Forge Path Toward QC & Supply Chain Integration: "Revolutionizing Lab Operations for Enhanced Efficiency" [Yahoo! Finance]Yahoo! Finance
- Global Anti-Depressant Drugs Market to Register Incremental Growth by 2030, Predicts DelveInsight | Key Companies - AbbVie, AstraZeneca, Eli Lilly and Company, GlaxoSmithKline, H. Lundbeck AS, Johnson & Johnson, Pfizer [Yahoo! Finance]Yahoo! Finance
- AstraZeneca PLC (NASDAQ: AZN) was upgraded by analysts at Deutsche Bank Aktiengesellschaft from a "sell" rating to a "hold" rating.MarketBeat
- Emphysema Treatment Market to Reach $8.7 Billion, Globally, by 2032 at 3.3% CAGR: Allied Market Research [Yahoo! Finance]Yahoo! Finance
AZN
Sec Filings
- 4/11/24 - Form 6-K
- 4/11/24 - Form 6-K
- 4/8/24 - Form 6-K
- AZN's page on the SEC website